Showing results (31-40 of 78) with videos related to
Sort By:
Pageof 8
Cancer Detection and Prevention|July 18, 2008
Loss of heterozygosity in the RAD51 and BRCA2 regions in breast cancerMaria Nowacka-Zawisza, Magdalena Bryś, Hanna Romanowicz-Makowska, et al.Folia Histochemica Et Cytobiologica|January 19, 2012
Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part IIKatarzyna Starska, Ewa Głowacka, Andrzej Kulig, et al.Cellular & Molecular Biology Letters|December 21, 2006
Genetic instability in the RAD51 and BRCA1 regions in breast cancerMaria Nowacka-Zawisza, Magdalena Bryś, Hanna Romanowicz-Makowska, et al.Folia Histochemica Et Cytobiologica|January 19, 2012
The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part IKatarzyna Starska, Ewa Głowacka, Andrzej Kulig, et al.Sao Paulo Medical Journal = Revista Paulista De Medicina|October 13, 2009
Expression of estrogen and progesterone receptor genes in endometrium, myometrium and vagina of postmenopausal women treated with estriolMagdalena Bryś, Krzysztof Szyłło, Hanna Romanowicz-Makowska, et al.Medical Oncology (Northwood, London, England)|October 5, 2015
Loss of heterozygosity for chromosomal regions 15q14-21.1, 17q21.31, and 13q12.3-13.1 and its relevance for prostate cancerMaria Nowacka-Zawisza, Ewa Forma, Maciej Walczak, et al.Cellular Oncology (Dordrecht, Netherlands)|January 5, 2018
Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancerKatarzyna Starska, Ewa Forma, Iwona Lewy-Trenda, et al.Ginekologia Polska|January 25, 2014
[Expression of E-cadherin and beta1-integrin mRNA in endometrial cancer]Katarzyna Wójcik-Krowiranda, Ewa Forma, Agnieszka Zaczek, et al.Plos One|June 5, 2018
Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cellsEwa Forma, Paweł Jóźwiak, Piotr Ciesielski, et al.Toxicology and Applied Pharmacology|October 27, 2016
Identification of the key pathway of oxazolinoanthracyclines mechanism of action in cells derived from human solid tumorsMarta Denel-Bobrowska, Małgorzata Łukawska, Aneta Rogalska, et al.Pageof 8